Trial · NCT03185481
Results by group81
Each measurement the trial posted, group by group, in the words and numbers it posted.
61 to 80 of 81
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Benzodiazepine Discontinuation Symptoms Based on Physician Withdrawal Checklist (PWC-20) | PF-06649751 15 mg | Tremor-Tremulousness / Mild | 0 | Participants | |
| Number of Participants With Benzodiazepine Discontinuation Symptoms Based on Physician Withdrawal Checklist (PWC-20) | PF-06649751 15 mg | Tremor-Tremulousness / Moderate | 0 | Participants | |
| Number of Participants With Benzodiazepine Discontinuation Symptoms Based on Physician Withdrawal Checklist (PWC-20) | PF-06649751 15 mg | Tremor-Tremulousness / Severe | 1 | Participants | |
| Number of Participants With Benzodiazepine Discontinuation Symptoms Based on Physician Withdrawal Checklist (PWC-20) | PF-06649751 15 mg | Weakness / Not Present | 2 | Participants | |
| Number of Participants With Benzodiazepine Discontinuation Symptoms Based on Physician Withdrawal Checklist (PWC-20) | PF-06649751 15 mg | Weakness / Mild | 2 | Participants | |
| Number of Participants With Benzodiazepine Discontinuation Symptoms Based on Physician Withdrawal Checklist (PWC-20) | PF-06649751 15 mg | Weakness / Moderate | 0 | Participants | |
| Number of Participants With Benzodiazepine Discontinuation Symptoms Based on Physician Withdrawal Checklist (PWC-20) | PF-06649751 15 mg | Weakness / Severe | 0 | Participants | |
| Change From Baseline for Hauser Participant Diary Data in Daily OFF Time | PF-06649751 15 mg | Baseline | 3.25 | Standard Deviation NA | Hours |
| Change From Baseline for Hauser Participant Diary Data in Daily OFF Time | PF-06649751 15 mg | Day 21 | 0.00 | Standard Deviation NA | Hours |
| Change From Baseline for Hauser Participant Diary Data in Daily OFF Time | PF-06649751 15 mg | Day 35 | -0.42 | Standard Deviation NA | Hours |
| Change From Baseline for Hauser Participant Diary Data in Daily ON Time With Troublesome Dyskinesia | PF-06649751 15 mg | Baseline | 0.00 | Standard Deviation NA | Hours |
| Change From Baseline for Hauser Participant Diary Data in Daily ON Time With Troublesome Dyskinesia | PF-06649751 15 mg | Day 21 | 0.00 | Standard Deviation NA | Hours |
| Change From Baseline for Hauser Participant Diary Data in Daily ON Time With Troublesome Dyskinesia | PF-06649751 15 mg | Day 35 | 0.00 | Standard Deviation NA | Hours |
| Change From Baseline for Hauser Participant Diary Data in Daily ON Time Without Troublesome Dyskinesia | PF-06649751 15 mg | Baseline | 9.58 | Standard Deviation NA | Hours |
| Change From Baseline for Hauser Participant Diary Data in Daily ON Time Without Troublesome Dyskinesia | PF-06649751 15 mg | Day 21 | 1.17 | Standard Deviation NA | Hours |
| Change From Baseline for Hauser Participant Diary Data in Daily ON Time Without Troublesome Dyskinesia | PF-06649751 15 mg | Day 35 | 2.42 | Standard Deviation NA | Hours |
| Change From Baseline in Movement Disorder Society Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Parts I, II, III, IV, and Total Score | PF-06649751 15 mg | Part I Score | -1.5 | Full Range -15 to 9 | Units on a scale |
| Change From Baseline in Movement Disorder Society Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Parts I, II, III, IV, and Total Score | PF-06649751 15 mg | Part II Score | 0 | Full Range -10 to 9 | Units on a scale |
| Change From Baseline in Movement Disorder Society Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Parts I, II, III, IV, and Total Score | PF-06649751 15 mg | Part III Score | -2.5 | Full Range -9 to 11 | Units on a scale |
| Change From Baseline in Movement Disorder Society Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Parts I, II, III, IV, and Total Score | PF-06649751 15 mg | Part IV Score | 0 | Full Range -3 to 6 | Units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03185481/results?page=4